Outcome of neoadjuvant-treated young patients with hormone receptor-positive breast cancer.

被引：0
|
作者：
Mayte Villarreal-Garza, Cynthia
Arce-Salinas, Claudia
Lasa, Federico
Reynoso, Nancy
Antonio Matus, Juan
Lara-Medina, Fernando
Bargallo-Rocha, Enrique
Flores Diaz, Diana Fabiola
Shaw, Robin J.
Alvarado-Miranda, Alberto
Jaime Castaneda, Noel
Alejandra Martinez-Cannon, Bertha
Mohar, Alejandro
机构：
[1] Inst Nacl Cancerol, Mexico City, DF, Mexico
[2] Tecnol Monterrey, San Pedro Garza Garcia, Mexico
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e11577
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11577
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapy
    Seber, Erdogan Selcuk
    Iriagac, Yakup
    Cavdar, Eyyup
    Karaboyun, Kubilay
    Avci, Okan
    Yolcu, Ahmet
    Gurdal, Sibel Oezkan
    Oznur, Meltem
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (03): : 434 - 439
  • [2] Proteomic prediction in hormone receptor-positive breast cancer.
    Hennessy, B. T.
    Gonzalez-Angulo, A. M.
    Lu, Y.
    Tibes, R.
    Siwak, D.
    Sahin, A.
    Kau, S.
    Hortobagyi, G. N.
    Valero, V.
    Mills, G. B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 13S - 13S
  • [3] Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy
    Choi, Hee Jun
    Lee, Jun Ho
    Jung, Chang Shin
    Ryu, Jai Min
    Chae, Byung Joo
    Lee, Se Kyung
    Yu, Jong Han
    Kim, Seok Won
    Nam, Seok Jin
    Lee, Jeong Eon
    Jung, Youn Joo
    Kim, Hyun Yul
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (27) : 6398 - 6406
  • [4] Oncology efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy
    Choi, H. J.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S287 - S287
  • [5] Use of platinum-based neoadjuvant chemotherapy (NACT) in patients (pts) with hormone receptor-positive breast cancer.
    Kyriakopoulos, Christos
    Ambros, Tadeu Frantz
    Montero, Alberto J.
    Hurley, Judith
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Clinical Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
    Raphael, Jacques
    Kiss, Alex
    Nofech-Mozes, Sharon
    Trudeau, Maureen
    [J]. CLINICAL BREAST CANCER, 2018, 18 (06) : E1381 - E1387
  • [7] TISSUE PROTEOME ANALYSIS OF HORMONE RECEPTOR-POSITIVE BREAST CANCER.
    Yoneten, K. Karaosmanoglu
    Gunes, A.
    Kasap, M.
    Utkan, N. Z.
    Akpinar, G.
    Gurel, B.
    Guler, S. A.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [8] Monitoring for response and recurrence in neoadjuvant-treated hormone receptor-positive HER2-negative breast cancer by personalized circulating tumor DNA testing
    Magbanua, Mark Jesus M.
    Rugo, Hope
    Swigart, Lamorna A. Brown
    Ahmed, Ziad
    Hirst, Gillian L.
    Wolf, Denise M.
    Lu, Ruixiao
    Kalashnikova, Ekaterina
    Renner, Derrick
    Rodriguez, Angel
    Liu, Minetta C.
    Yau, Christina
    Esserman, Laura J.
    Van't Veer, Laura
    DeMichele, Angela
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [9] Predictors of response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer.
    Moore, Halle C. F.
    Maiti, Baidehi
    Rybicki, Lisa A.
    Booth, Christine
    Abraham, Jame
    Budd, G. Thomas
    Andresen, Steven Ware
    Downs-Kelly, Erinn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Neoadjuvant therapy for hormone receptor-positive breast cancer: challenges and advances
    Metzger, O.
    [J]. CANCER RESEARCH, 2020, 80 (04)
12345